VanEck's BDC Income ETF (BIZD) shows a high 9.69% expense ratio, which includes fees and expenses charged by the underlying business development companies (BDCs) it invests in, as well as the fund's own fees. This combined figure can mislead investors who may think the fund charges this high fee directly. The yields and returns reported by BIZD already reflect these costs, so investors effectively pay once through the fund’s income distributions. Understanding this layered fee structure is crucial for evaluating the fund’s true cost and income potential. Investors should compare the net yields after all fees to other credit risk investments before deciding to buy.
VanEck's BDC Income ETF (BIZD) shows a high expense ratio including multiple fees. For readers following Financials, here is Pluang's market snapshot as of Nov 05, 2026 18:11 WIB: 91 of 142 US Financial stocks rose, 45 fell. Deutsche Bank AG (DB) traded at USD 37.65, up 2.50%, with 93% sell orders and a typical hold time of 81 days. Enact Holdings Inc (ACT) was at USD 47.05, down 2.47%, held typically for 32 days. ICICI Bank Limited (IBN) rose 2.46% to USD 32.03, with a 14-day hold time.
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...
Northern Discovery Metals has finalized the acquisition of a 100% interest in the Cibola copper-gold project in British Columbia from Orogen Royalties. The project covers about 3,567 hectares near Houston, BC, in a region known for porphyry copper de...
Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...
Perimeter Group Inc. announced a net income of $304.5 million for Q3 2026, reversing a prior year loss of $90.7 million, with net sales up 24% to $389.9 million. Growth was driven by a 14% increase in Fire Safety sales and an 84% surge in Specialty P...
